Widely accepted as the gold-standard for ultra low-noise patch clamp recordings, the Axopatch™ 200B Capacitor Feedback Patch Clamp Amplifier is the benchmark for single-channel recordings and other applications that require an excellent signal-to-noise ratio. By introducing active cooling of components in the headstage to well below 0°C, the open-circuit noise in patch mode has been reduced to unprecedented levels, as low as <15 fA (RMS) at 0.1 - 1 kHz. This translates into significantly lower noise during patch clamp recordings. A headstage that can be switched to resistive mode ensures superb performance in whole-cell recordings, too. This makes the Axopatch 200B System the amplifier of choice for a scientist who performs basic research in the ion channel field and is the reason why researchers purchased thousands of these amplifiers from Molecular Devices over the past decade.
In addition to ultra-low noise and whole-cell performance, the slim design of the headstage improves electrode access to the preparation by making it easier to fit under your microscope. The Axopatch 200B Amplifier gives you the utmost flexibility through three recording configurations in a single headstage: one patch and two whole cell ranges, with capacitance compensation ranges of 100 pF and 1000 pF. Increased voltage and current command ranges (up to ±1V) are useful for electrochemical measurements. The built-in capacitance dithering capability enables highly accurate capacitance measurements. Seal test has become more versatile, featuring current steps in current clamp mode as well as voltage steps in voltage clamp mode. The recording bandwidth has been extended up to 100 kHz, allowing you to capture even the fastest events. Series resistance compensation is active in current clamp as well as in voltage clamp mode to enable bridge balance operation and improve amplifier performance.
Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.Therapeutic Approach Gives Hope for Multiple Myeloma A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Genomic Signature Shared by Five Types of Cancer National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Genetic Cause of Rare Allergy Institute has identified a genetic mutation responsible for a rare form of inherited hives induced by vibratory urticaria.Battery Component Found to Harm Key Soil Microorganism The material at the heart of the lithium ion batteries that power electric vehicles, laptop computers and smartphones has been shown to impair a key soil bacterium, according to new research.Keeping Tumor Growth at Bay Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.